$60K Grant to Support Work on Biomarkers for ALS, Like Disorders
Applications for a $60,000 one-year grant are now open for researchers working to discover or validate biomarkers for amyotrophic…
Mary graduated from Wayne State University with a degree in journalism. She began her career at United Press International, then spent a decade reporting for the Bureau of National Affairs, Inc. (now Bloomberg Industry Group). Mary has written extensively for The New York Times, and her work has appeared in publications such as Time, Newsweek, Fortune, and the Chicago Tribune. She’s won a Society of Professional Journalists award for outstanding reporting.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Applications for a $60,000 one-year grant are now open for researchers working to discover or validate biomarkers for amyotrophic…
After a protracted campaign to make it happen, Major League Baseball (MLB) agreed to set aside each June 2…
To honor the memory of Broadway actor and singer Rebecca Luker, who died of complications due to amyotrophic…
Under a new local partnership, Mississippi residents who have amyotrophic lateral sclerosis (ALS) will have free access to communication…
ALS Focus has opened a new survey looking specifically at the needs and challenges of caregiving for people with …
Rare Disease Day at NIH, organized by the National Institutes of Health (NIH) and taking place on March 1,…
The My Name’5 Doddie Foundation has donated a total of £300,000 (about $420,600) to two U.K. nonprofits to support…
With a new version of a low-cost eye-tracking system called EyeWriter, artists and others who are paralyzed due to…
Scores of virtual events are afoot around the world to mark Rare Disease Day 2021 on Feb. 28. The…
While progress was made last year on newborn screening and other policy issues critical to rare disease patients, a “…